Neuroprotective Function of the PGE2 EP2 Receptor in Cerebral Ischemia

Journal of Neuroscience

Volumn 24, Issue 1, 2004, Pages 257-268

  McCullough, Louise ^a   Wu, Liejun ^a   Haughey, Norman ^a   Liang, Xibin ^a   Hand, Tracey ^a   Wang, Qian ^a   Breyer, Richard M ^b   Andreasson, Katrin ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

cAMP; Cerebral cortex; EP2 receptor; Hippocampus; Neuroprotection; PGE2; Prostaglandin; Stroke

Indexed keywords

ARACHIDONIC ACID; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; INOSITOL PHOSPHATE; PROSTACYCLIN; PROSTAGLANDIN E2; GLUTAMIC ACID; ISOENZYME; NEUROPROTECTIVE AGENT; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN EP2 RECEPTOR; PROSTAGLANDIN SYNTHASE;

ANIMAL CELL; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN PERFUSION; CALCIUM MOBILIZATION; CATALYSIS; CELL SURVIVAL; ENZYME ACTIVATION; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE FUNCTION; NERVE INJURY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; ANIMAL; BIOSYNTHESIS; BRAIN INFARCTION; C57BL MOUSE; CELL CULTURE; CELL DEATH; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; FOREBRAIN; GENETICS; HIPPOCAMPUS; METABOLISM; MOUSE; NERVE CELL; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TRANSIENT ISCHEMIC ATTACK;

ANIMALS; CELL DEATH; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL INFARCTION; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLOOXYGENASE 2; DINOPROSTONE; GLUTAMIC ACID; HIPPOCAMPUS; ISCHEMIC ATTACK, TRANSIENT; ISOENZYMES; MICE; MICE, INBRED C57BL; NEURONS; NEUROPROTECTIVE AGENTS; PROSENCEPHALON; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PROSTAGLANDIN E;

EID: 0842322738     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4485-03.2004     Document Type: Article

References (102)

1. Abdel-Hamid KM, Tymianski M (1997) Mechanisms and effects of intracellular calcium buffering on neuronal survival in organotypic hippocampal cultures exposed to anoxia/aglycemia or to excitotoxins. J Neurosci 17:3538-3553.
2. Abe H, Takeshita T, Nagata K, Arita T, Endo Y, Fujita T, Takayama H, Kubo M, Sugamura K (1999) Molecular cloning, chromosome mapping and characterization of the mouse CRTH2 gene, a putative member of the leukocyte chemoattractant receptor family. Gene 227:71-77.
3. Adams J, Collaco-Moraes Y, de Belleroche J (1996) Cyclooxygenase-2 induction in cerebral cortex: an intracellular response to synaptic excitation. J Neurochem 66:6-13.
4. Akaike A, Kaneko S, Tamura Y, Nakata N, Shiomi H, Ushikubi F, Narumiya S (1994) Prostaglandin E2 protects cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxcity. Brain Res 663:237-244.
5. Alkayed NJ, Harakumi I, Kimes AS, London ED, Traystman RJ, Hurn PD (1998) Gender-linked injury in experimental stroke. Stroke 29:159-165.
6. Amateau SK, McCarthy MM (2002) A novel mechanism of dendritic spine plasticity involving estradiol induction of prostaglandin-E2. J Neurosci 22:8586-8596.
7. Andreasson KI, Savonenko A, Vidensky S, Goellner JJ, Zhang Y, Shaffer A, Kaufmann WE, Worley PF, Isakson P, Markowska AL (2001) Age-dependent cognitive deficits and neuronal apoptosis in cyclooxygenase-2 transgenic mice. J Neurosci 21:8198-8209.
8. Batshake B, Nilsson C, Sundelin J (1995) Molecular characterization of the mouse prostanoid EP1 receptor gene. Eur J Biochem 231:809-814.
9. Bezzi P, Carmignoto G, Pasti L, Vesce S, Rossi D, Rizzini BL, Pozzan T, Volterra A (1998) Prostaglandins stimulate calcium dependent glutamate release in astrocytes. Nature 391:281-285.
10. Blackman S, Dawson G, Antonakis K, Le Breton G (1998) The identification and characterization of oligodendrocyte thromboxane A2 receptors. J Biol Chem 273:475-483.
11. Boie YSR, Sawyer N, Slipetz DM, Ungrin MD, Neuschafer-Rube F, Puschel GP, Metters KM, Abramovitz M (1997) Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes. Eur J Pharmacol 340:227-241.
12. Breyer RM, Bagdassarian CK, Myers SA, Breyer MD (2001) Prostanoid receptors: subtypes and signaling. Annu Rev Pharmacol Toxicol 41:661-690.
13. Breyer RM, Kennedy CR, Zhang Y, Guan Y, Breyer MD (2002) Targeted gene disruption of the prostaglandin E2 EP2 receptor. Adv Exp Med Biol 507:321-326.
14. Brock TG, McNish RW, Peters-Golden M (1999) Arachidonic acid is preferentially metabolized by cyclooxygenase-2 to prostacyclin and prostaglandin E2. J Biol Chem 274:11660-11666.
15. Caggiano AO, Kraig RP (1999) Prostaglandin E receptor subtypes in cultured rat microglia and their role in reducing lipopolysaccharide-induced interleukin-1β production. J Neurochem 72:565-575.
16. Carlson NG (2003) Neuroprotection of cultured cortical neurons mediated by the cyclooxygenase-2 inhibitor APHS can be reversed by a prostanoid. J Neurosci Res 71:71-88.
17. Cazevielle C, Muller A, Meynier F, Dutrait N, Bonne C (1994) Protection by prostaglandins from glutamate toxicity in cortical neurons. Neurochem Int 24:156-159.
18. Chen C, Magee JC, Bazan NG (2002) Cyclooxygenase-2 regulates prostaglandin E2 signaling in hippocampal long-term synaptic plasticity. J Neurophysiol 87:2851-2857.
19. Chijiwa T, Mishima A, Hagiwara N, Sano M, Hayashi K, Inoue Y, Naito K, Toshioka T, Hidaka H (1990) Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase (H89) of PC12D pheochromocytoma cells. J Biol Chem 265:5267-5272.
20. Czapiga M, Colton CA (1999) Function of microglia in organotypic slice cultures. J Neurosci Res 56:644-651.
21. D'Mello S, Galli C, Ciotti T, Calissano P (1993) Induction of apoptosis in cerebellar granule cells by low potassium: inhibition of death by insulin-like growth factor I and cAMP. Proc Natl Acad Sci USA 23:10989-10993.
22. David JC, Yamada KA, Bagwe MR, Goldberg MP (1996) AMPA receptor activation is rapidly toxic to cortical astrocytes when desensitization is blocked. J Neurosci 16:200-209.
23. Dore S, Otsuka T, Mito T, Sugo N, Hand T, Wu L, Hurn P, Traystman R, Andreasson K (2003) Neuronal overexpression of cyclooxygenase-2 increases cerebral infarction. Ann Neurol 54:155-162.
24. Drachman DB, Frank K, Dykes-Hoberg M, Teismann P, Almer G, Przedborski S, Rothstein JD (2002) Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS. Ann Neurol 52:771-778.
25. Dumuis A, Sebben M, Haynes L, Pin JP, Bockaert J (1988) NMDA receptors activate the arachidonic acid cascade system in striatal neurons. Nature 336:68-70.
26. Ek M, Arias C, Sawchenko P, Ericsson-Dahlstrand A (2000) Distribution of the EP3 prostaglandin E(2) receptor subtype in the rat brain: relationship to sites of interleukin-1-induced cellular responsiveness. J Comp Neurol 428:5-20.
27. Eling TE, Thompson DC, Foureman GL, Curtis JF, Hughes MF (1990) Prostaglandin H synthase and xenobiotic oxidation. Annu Rev Pharmacol Toxicol 330:1-45.
28. Fedyk ER, Ripper JM, Brown DM, Phipps RP (1996) A molecular analysis of PGE receptor (EP) expression on normal and transformed B lymphocytes: coexpression of EP1, EP2, EP3beta and EP4. Mol Immunol 33:33-45.
29. Feng ZH, Wang, TG, Li DD, Fung P, Wilson BC, Liu B, Ali SF, Langenbach R, Hong JS (2002) Cyclooxygenase-2-deficient mice are resistant to 1-methyl-4-phenyl1, 2, 3, 6-tetrahydropyridine-induced damage of dopaminergic neurons in the substantia nigra. Neurosci Lett 329:354-358.
30. Gardiner PJ (1986) Characterization of prostanoid relaxant/inhibitory receptors using a highly selective agonist, TR4979. Br J Pharmacol 87:45-56.
31. Hailer NP, Jarhult JD, Nitsch R (1996) Resting microglial cells in vitro: analysis of morphology and adhesion molecule expression in organotypic hippocampal slice cultures. Glia 18:319-331.
32. Hanson M, Shen S, Wiemelt A, McMorris F, Barres B (1998) Cyclic AMP elevation is sufficient to promote the survival of spinal motor neurons in vitro. J Neurosci 18:7361-7371.
33. Hastings TG (1995) Enzymatic oxidation of dopamine: the role of prostaglandin H synthase. J Neurochem 64:919-924.
34. Hewett SJ, Uliasz T, Vidwans A, Hewett JA (2000) Cyclooxygenase-2 contributes to N-methyl-D-aspartate mediated neuronal cell death in primary cortical cultures. J Pharmacol Exp Ther 293:417-425.
35. Hirai H, Tanaka K, Yoshie O, Ogawa K, Kenmotsu K, Takamori Y, Ichimasa M, Sugamura K, Nakamura M, Takano S, Nagata K (2001) Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med 193:255-261.
36. Hsu K, Kan W (1996) Thromboxane A2 agonist modulation of excitatory synaptic transmission in the rat hippocampal slice. Br J Pharmacol 118:2220-2227.
37. Hsu K, Huang C, Kan W, Gean P (1996) TXA2 agonists inhibit high-voltage-activated calcium channels in rat hippocampal CA1 neurons. Am J Physiol 271:C1269-C1277.
38. Huang M, Stolina M, Sharma S, Mao JT, Zhu L, Miller PW, Wollman J, Herschman H, Dubinett SM (1998) Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production. Cancer Res 58:1208-1216.
39. Jakobsen B, Zimmer J (2001) Chronic exposure of kainate and NBQX changes AMPA toxicity in hippocampal slice cultures. NeuroReport 12:3593-3597.
40. Jay TM, Lucignani G, Crane AM, Jehle J, Sokoloff L (1988) Measurement of local cerebral blood flow with [14C]iodoantipyrine in the mouse. J Cereb Blood Flow Metab 8:121-129.
41. Kase H, Iwahashi K, Nakanishi S, Matsuda Y, Yamada K, Takahashi M, Murakata C, Sato A, Kaneko M (1987) K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem Biophys Res Commun 142:436-440.
42. Kennedy CR, Zhang Y, Brandon S, Guan Y, Coffee K, Funk CD, Magnuson MA, Oates JA, Breyer MD, Breyer RM (1999) Salt-sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor. Nat Med 5:217-220.
43. Kiriyama M, Ushikubi F, Kobayashi T, Hirata M, Sugimoto Y, Narumiya S (1997) Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells. Br J Pharmacol 122:217-224.
44. Kitanaka J, Ishibashi T, Baba A (1993) Phloretin as an antagonist of prostaglandin F2 alpha receptor in cultured rat astrocytes. J Neurochem 60:704-708.
45. Lerea LS, Carlson NG, Simonato M, Morrow J, Roberts JL, McNamara JO (1997) Prostaglandin F 2alpha is required for NMDA receptor-mediated induction of c-fos mRNA in dentate gyrus neurons. J Neurosci 17:117-124.
46. Lin TN, He YY, Wu G, Khan M, Hsu CY (1993) Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke 24:117-121.
47. Liu D, Li L, Augustus L (2001) Prostaglandin release by spinal cord injury mediates production of hydroxyl radical, malondialdehyde and cell death: a site of the neuroprotective action of methylprednisolone. J Neurochem 77:1036-1047.
48. Longa EZ, Weinstein PR, Carlson S, Cummins R (1989) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1:84-91.
49. Lu X, Wyszynski M, Sheng M, Baudry M (2001) Proteolysis of glutamate receptor-interacting protein by calpain in rat brain: implications for synaptic plasticity. J Neurochem 77:1553-1560.
50. Matsumura K, Watanabe Y, Onoe H, Watanabe Y (1995) Prostacyclin receptor in the brain and central terminals of the primary sensory neurons: an autoradiographic study using a stable prostacyclin analogue [3H]iloprost. Neuroscience 65:493-503.
51. McCullough LD, Alkayed N, Williams M, Traystman RJ, Hurn PD (2001) Post-ischemic estrogen reduces hypoperfusion and secondary ischemia after experimental stroke. Stroke 32:796-802.
52. McCullough LD, Blizzard K, Simpson ER, Oz OK, Hurn PD (2003) Aromatase cytochrome P450 and extragonadal estrogen play a role in ischemic neuroprotection. J Neurosci 23:8701-8705.
53. Miettinen S, Fusco FR, Yrjanheikki J, Keinanen R, Hirvonen T, Roivainen R, Narhi M, Hokfelt T, Koistinaho J (1997) Spreading depression and focal brain ischemia induce cyclooxygenase-2 in cortical neurons through N-methyl-D-aspartic acid-receptors and phospholipase A2. Proc Natl Acad Sci USA 94:6500-6505.
54. Mirjany M, Ho L, Pasinetti GM (2002) Role of cyclooxygenase-2 in neuronal cell cycle activity and glutamate-mediated excitotoxicity. J Pharmacol Exp Ther 301:494-500.
55. Mizoguchi A, Eguchi N, Kimura K, Kiyohara Y, Qu WM, Huang ZL, Mochizuki T, Lazarus M, Kobayashi T, Kaneko T, Narumiya S, Urade Y, Hayaishi O (2001) Dominant localization of prostaglandin D receptors on arachnoid trabecular cells in mouse basal forebrain and their involvement in the regulation of non-rapid eye movement sleep. Proc Natl Acad Sci USA 98:11674-11679.
56. Montine TJ, Milatovic D, Gupta RC, Valyi-Nagy T, Morrow JD, Breyer RM (2002) Neuronal oxidative damage from activated innate immunity is EP2 receptor-dependent. J Neurochem 83:463-470.
57. Munroe DG, Wang EY, MacIntyre JP, Tam SS, Lee DH, Taylor GR, Zhou L, Plante RK, Kazmi SM, Bauerle PA, et al. (1995) Novel intracellular signaling function of prostaglandin H synthase-1 in NF-kappa B activation. J Inflamm 45:260-268.
58. Nakagomi T, Sasaki T, Ogawa H, Noguchi M, Saito I, Takakura K (1990) Immunohistochemical localization of prostaglandin F2 alpha in reperfused gerbil brain. Neurol Med Chir (Tokyo) 30:223-228.
59. Nakahata N, Ishimoto H, Kurita M, Ohmori K, Takahashi A, Nakanishi H (1992) The presence of thromboxane A2 receptors in cultured astrocytes from rabbit brain. Brain Res 583:100-104.
60. Nakayama M, Uchimura K, Zhu RL, Nagayama T, Rose ME, Stetler RA, Isakson PC, Chen J, Graham SH (1998) Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia. Proc Natl Acad Sci USA 95:10954-10959.
61. Newell DW, Barth A, Papermaster V, Malouf AT (1995) Glutamate and non-glutamate receptor mediated toxicity caused by oxygen and glucose deprivation in organotypic hippocampal cultures. J Neurosci 15:7702-7711.
62. Nishihara I, Minami T, Watanabe Y, Ito S, Hayaishi O (1995) Prostaglandin E2 stimulates glutamate release from synaptosomes of rat spinal cord. Neurosci Lett 18:57-60.
63. Nishihara M, Yokotani K, Inoue S, Osumi Y (1999) U-46619, a selective Thromboxane A2 mimetic, inhibits the release of endogenous noradrenaline from the rat hippocampus in vitro. Jpn J Pharmacol 82:226-231.
64. Nogawa S, Zhang F, Ross ME, Iadecola C (1997) Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. J Neurosci 17:2746-2755.
65. Ogawa H, Sasaki T, Kassell NF, Nakagomi T, Lehman RM, Hongo K (1987) Immunohistochemical demonstration of increase in prostaglandin F2-alpha after recirculation in global ischemic rat brains. Acta Neuropathol 75:62-68.
66. Oida H, Hirata M, Sugimoto Y, Ushikubi F, Ohishi H, Mizuno N, Ichikawa A, Narumiya S (1997) Expression of messenger RNA for the prostaglandin D receptor in the leptomeninges of the mouse brain. FEBS Lett 417:53-56.
67. Pasinetti GM, Aisen PS (1998) Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain. Neuroscience 87:319-324.
68. Pompl PN, Ho L, Bianchi M, McManus T, Qin W, Pasinetti GM (2003) A therapeutic role for cyclooxygenase-2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis. FASEB J 10:1096.
69. Prasad KN, Hovland AR, La Rosa FG, Hovland PG (1998a) Prostaglandins as putative neurotoxins in Alzheimer's disease. Proc Soc Exp Biol Med 219:120-125.
70. Prasad KN, La Rosa FG, Prasad JE (1998b) Prostaglandins act as neurotoxin for differentiated neuroblastoma cells in culture and increase levels of ubiquitin and beta-amyloid. In Vitro Cell Dev Biol Anim 34:265-274.
71. Rao A, Kim E, Sheng M, Craig AM (1998) Heterogeneity in the molecular composition of excitatory postsynaptic sites during development of hippocampal neurons in culture. J Neurosci 18:1217-1229.
72. Rusa R, Alkayed NJ, Crain B, Traystman RJ, Kimes AS, London ED, Klaus JA, Hurn PD (1999) 17β-Estradiol reduces stroke injury in estrogen-deficient female animals. Stroke 30:1665-1670.
73. Rydel R, Greene L (1988) cAMP analogs promote survival and neurite outgrowth in cultures of rat sympathetic and sensory neurons independently of nerve growth factor. Proc Natl Acad Sci USA 85:1257-1261.
74. Sampei KG, S., Alkayed N, Crain B, Korach K, Traystman R, Demas G, Nelson R, Hurn P (2000) Stroke in estrogen receptor-alpha-deficient mice. Stroke 31:738-743.
75. Sanzgiri R, Araque A, Haydon P (1999) Prostaglandin E2 stimulates glutamate receptor dependent astrocyte neuromodulation in cultured hippocampal cells. J Neurobiol 41:221-229.
76. Sawada M, Alkayed NJ, Goto S, Crain BJ, Traystman RJ, Shaivitz A, Nelson RJ, Hurn PD (2000) Estrogen receptor antagonist ICI182, 780 exacerbates ischemic injury in female mouse. J Cereb Blood Flow Metab 20:112-118.
77. Schmidt H, Tlustochowska A, Stuertz K, Djukic M, Gerber J, Schutz E, Kuhnt U, Nau R (2001) Organotypic hippocampal cultures. A model of brain tissue damage in Streptococcus pneumoniae meningitis. J Neuroimmunol 113:30-39.
78. Separovic D, Dorman RV (1993) Prostaglandin F2 alpha synthesis in the hippocampal mossy fiber synaptosomal preparation: I. Dependence in arachidonic acid, phospholipase A2, calcium availability and membrane depolarization. Prostaglandins Leukot Essent Fatty Acids 48:127-137.
79. Seregi A, Forstermann U, Heldt R, Hertting G (1985) The formation and regional distribution of prostaglandins D2 and F2 alpha in the brain of spontaneously convulsing gerbils. Brain Res 337:171-174.
80. Sheller JR, Mitchell D, Meyrick B, Oates J, Breyer R (2000) EP(2) receptor mediates bronchodilation by PGE(2) in mice. J Appl Physiol 88:2214-2218.
81. Smith WL, Marnett LJ, DeWitt DL (1991) Prostaglandin and thromboxane biosynthesis. Pharmacol Ther 48:153-179.
82. Stoppini L, Buchs PA, Muller D (1991) A simple method for organotypic cultures of nervous tissue. J Neurosci Methods 37:173-182.
83. Streit WJ (2000) Microglial response to brain injury. Toxicol Pathol 28:28-30.
84. Sugimoto Y, Shigemoto R, Namba T, Negishi M, Mizuno N, Narumiya S, Ichikawa A (1994) Distribution of the messenger RNA for the prostaglandin E receptor subtype EP3 in the mouse nervous system. Neuroscience 62:919-928.
85. Takadera T, Yumoto H, Tozuka Y, Ohyashiki T (2002). Prostaglandin E2 induces caspase-dependent apoptosis in rat cortical cells. Neurosci Lett 317:61-64.
86. Tani KNA, Ishida A, Egashira H, Sagawa K, Harada H, Ogawa M, Maruyama T, Ohuchida S, Nakai H, Kondo K, Toda M (2002) Development of a highly selective EP2-receptor agonist. Part 2: identification of 16-hydroxy-17, 17-trimethylene 9beta-chloro PGF derivatives. Bioorg Med Chem 10:1107-1114.
87. Tasker RC, Coyle JT, Vornov JJ (1992) The regional vulnerability to hypoglycemia-induced neurotoxicity in organotypic hippocampal culture: protection by early tetrodotoxin or delayed MK-801. J Neurosci 12:4298-4308.
88. Teismann P, Tieu K, Choi DK, Wu DC, Naini A, Hunot S, Vila M, Jackson-Lewis V, Przedborski S (2003) Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration. Proc Natl Acad Sci USA 100:5473-5478.
89. Trifan OC, Smith RM, Thompson BD, Hla T (1999) Overexpression of cyclooxygenase-2 induces cell cycle arrest. Evidence for a prostaglandin-independent mechanism. J Biol Chem 274:34141-34147.
90. Vidensky S, Zhang Y, Hand T, Goellner J, Isakson P, Andreasson K (2003) Neuronal overexpression of COX-2 results in dominant production of PGE2 and altered fever response. Neuromol Med 3:15-27.
91. Vincent VA, Robinson CC, Simsek D, Murphy GM (2002a) Macrophage colony stimulating factor prevents NMDA-induced neuronal death in hippocampal organotypic cultures. J Neurochem 82:1388-1397.
92. Vincent VA, Selwood SP, Murphy Jr GM (2002b) Proinflammatory effects of M-CSF and A beta in hippocampal organotypic cultures. Neurobiol Aging 23:349-362.
93. Vornov JJ, Tasker RC, Coyle JT (1991) Direct observation of the agonist-specific regional vulnerability to glutamate, NMDA, and kainate neurotoxicity in organotypic hippocampal cultures. Exp Neurol 114:11-22.
94. Vornov JJ, Tasker RC, Park J (1995) Neurotoxicity of acute glutamate transport blockade depends on coactivation of both NMDA and AMPA/kainate receptors in organotypic hippocampal cultures. Exp Neurol 133:7-17.
95. Walton MR, Dragunow I (2000) Is CREB a key to neuronal survival? Trends Neurosci 23:48-53.
96. Watanabe Y, Tokumoto H, Yamashita A, Narumiya S, Mizuno N, Hayaishi O (1985) Specific bindings of prostaglandin D2, E2 and F2 alpha in postmortem human brain. Brain Res 342:110-116.
97. Watanabe Y, Matsumura K, Takechi H, Kato K, Morii H, Bjorkman M, Langstrom B, Noyori R, Suzuki M, Watanabe Y (1999) A novel subtype of prostacyclin receptor in the central nervous system. J Neurochem 72:2583-2592.
98. Wu VW, Schwartz JP (1998) Cell culture models for reactive gliosis: new perspectives. J Neurosci Res 51:675-681.
99. Xiang Z, Ho L, Valdellon J, Borchelt D, Kelley K, Spielman L, Aisen PS, Pasinetti GM (2002) Cyclooxygenase (COX)-2 and cell cycle activity in a transgenic mouse model of Alzheimer's disease neuropathology. Neurobiol Aging 23:327-334.
100. Yamagata K, Andreasson K, Kaufmann WE, Barnes CA, Worley PF (1993) Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 11:371-386.
101. Yamagata K, Matsumura K, Inoue W, Shiraki T, Suzuki K, Yasuda S, Sugiura H, Cao C, Watanabe Y, Kobayashi S (2001) Coexpression of microsomal-type prostaglandin E synthase with cyclooxygenase-2 in brain endothelial cells of rats during endotoxin-induced fever. J Neurosci 21:2669-2677.
102. Zhang J, Rivest S (1999) Distribution, regulation and colocalization of the genes encoding the EP2- and EP4-PGE2 receptors in the rat brain and neuronal responses to systemic inflammation. Eur J Neurosci 11:2651-2668.